Market research
688202.SHG Shanghai Medicilon Inc
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 13B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.71
Community
Investor discussion
1 comment
Sign in to join the 688202.SHG discussion.
5 years, 5 months ago
Shanghai Medicilon Inc is currently in a long term uptrend where the price is trading 44.0% above its 200 day moving average.
From a valuation standpoint, the stock is 251.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 33.8.
Shanghai Medicilon Inc's total revenue rose by 26.6% to $173M since the same quarter in the previous year.
Its net income has increased by 41.2% to $28M since the same quarter in the previous year.
Finally, its free cash flow grew by 704.9% to $36M since the same quarter in the previous year.
Based on the above factors, Shanghai Medicilon Inc gets an overall score of 4/5.